Thus, the selective down-regulation of LPS but not IFN-γ stimulated CD86 expression by monocytes may represent a central regulatory mechanism underlying the influence of laquinimod on APCs and in consequence on the putative auto-immune reaction in MS as a whole. Here, CD86 is linked to myeloid sarcoma.